Committee
BRD - Board
Role
The role of the Board is to define the strategic vision for the Association, provide policy guidance, set scientific direction for the Scientific Commission and to review its progress and output. The Board reviews and validates all documents and presentations produced and published under CORESTA’s name.
The Board typically meets twice a year, and holds specific meetings prior to and after the vote by the General Assembly.
Powers
The Board has full powers to act on behalf of the Association on all matters that do not specifically require the approval of a General Assembly.
The President is in charge of the execution of the decisions made by the Board and ensures, with the support of the General Secretariat, the proper functioning of the Association, which he represents with respect to all jurisdictions and acts of civil life.
Composition
The CORESTA Board comprises of 12 to 14 member-organisations. Ten are elected by the General Assembly from among the members of the Association, for a four-year tenure. Two to four other Members are co-opted by the elected Members, for a two-year tenure. Half of the elected Board Members and all co-opted ones are renewed every two years.
The members elected at the Board are requested to delegate as Administrators persons in active service within the Organisations who are well acquainted with the fields of activity of CORESTA and high-ranking, and therefore able to take an active part in Board activities.
The Board's Executive Committee consists of a President and a Vice-President, elected from among the administrators by secret ballot, for a two-year term, renewable once, and defined as intuitu personae.
Any Member Organisation may be a candidate to the Board.
Members 2022-2024
The Board Member Organisations and their representatives for the 2022-2024 period are as follows:
President: Dr Joseph Thompson
Vice-President: Mrs Anne Fisher
| Member | Represented by |
| Alliance One International, Inc. (USA) |
Dr Carlos Pulcinelli Global Project Manager |
| Altria Client Services (USA) |
Dr Jason Flora Associate Fellow, Scientific Strategy & Advocacy |
| British American Tobacco (UK) |
Ms Helena Digard Head of Science Plans and Claims |
| China National Tobacco Corporation (China) |
Dr Jianping Xie Chief Scientist of CNTC |
| delfort AG (Austria) |
Mr Huub Vizée Consultant |
| Imperial Brands (UK) |
Dr Joseph Thompson (President) Group Director, Science & Regulatory Affairs |
| Japan Tobacco Inc. (Japan) |
Dr Hitoshi Fujimoto Director |
| Körber Technologies Instruments GmbH (ex Borgwaldt KC GmbH) (Germany) |
Dr Nils Rose Consultant |
| KT&G Corporation (South Korea) |
Dr Man-Seok Seo Principal Research Scientist |
| Mother Murphy's Laboratories, Inc. (USA) |
Mr Eduardo Berea VP International Sales and Business Development |
| Reynolds American Inc. Services Co. (USA) |
Dr Rob Stevens Director, Scientific & Regulatory Affairs |
| Swedish Match AB (Sweden) |
Dr Johan Lindholm Vice President, Regulatory & Scientific Affairs |
| Universal Leaf Tobacco Company (USA) |
Mr Mauri Winegardner Vice President |
| University of Kentucky (USA) |
Mrs Anne Fisher (Vice President) Research Director, Kentucky Tobacco R&D Center |